Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I

Osteoblast Precursors, but Not Mature Osteoblasts, Move into Developing and Fractured Bones along with Invading Blood Vessels

(2010) Christa Maes et al.   DEVELOPMENTAL CELL

Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts

(2010) Weixi Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options

(2009) Florent Elefteriou et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1

(2009) S. Seitz et al.   OSTEOPOROSIS INTERNATIONAL

Osteo-Chondroprogenitor–Specific Deletion of the Selenocysteine tRNA Gene, Trsp, Leads to Chondronecrosis and Abnormal Skeletal Development: A Putative Model for Kashin-Beck Disease

(2009) Charlene M. Downey et al.   PLoS Genetics

Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin

(2008) Mateusz Kolanczyk et al.   BMC Medicine

NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F

(2008) S. Parrinello et al.   GENES & DEVELOPMENT

Conditional loss of PTEN leads to skeletal abnormalities and lipoma formation

(2008) Shu-Chen Hsieh et al.   MOLECULAR CARCINOGENESIS

Generalized metabolic bone disease in Neurofibromatosis type I

(2008) Nicola Brunetti-Pierri et al.   MOLECULAR GENETICS AND METABOLISM

Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1)

(2007) Aaron Schindeler et al.   BONE